| Symbol | TXG |
|---|---|
| Name | 10X GENOMICS, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 6230 STONERIDGE MALL ROAD, PLEASANTON, California, 94588, United States |
| Telephone | +1 925 401-7300 |
| Fax | — |
| — | |
| Website | https://www.10xgenomics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001770787 |
| Description | 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables. Additional info from NASDAQ: |
Teichmann Sarah A. 🔴 sold 7.6K shares of 10x Genomics, Inc. (TXG) at $57.29 Transaction Date: Aug 13, 2026 | Filing ID: 000359
Read more📋 STUELPNAGEL JOHN R (Director) plans to sell 20K shares of 10x Genomics, Inc. (at $57.75 each, total $1.2M) Filed: Aug 11, 2026 | ID: 000152
Read more10x Genomics - 10x Genomics Reports Second Quarter 2026 Financial Results
Read more10x Genomics - 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
Read more10x Genomics - 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
Read more10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
Read moreSaxonov Serge 🔴 sold 30.0K shares of 10x Genomics, Inc. (TXG) at $36.16 ($1.0M) Transaction Date: Jun 22, 2026 | Filing ID: 000293
Read more10x Genomics - 10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
Read more📋 Shehnaaz Suliman (Affiliate) plans to sell 6K shares of 10X Genomics, Inc. (at $32.22 each, total $184K) Filed: Jun 16, 2026 | ID: 000625
Read more